Healthcare

CMS finalized a mandatory Medicare Part B payment model using pricing benchmarks to test lower drug costs while maintaining care quality.

The program addresses longstanding challenges in clinical development, where bringing a new drug or biologic to market can take over a decade.

Agency launches nationwide recruitment drive to fill advisory committee vacancies and broaden scientific expertise and consumer input.

The FDA is considering changing to its tobacco product review framework as industry groups challenge the agency’s 2021 PMTA rule in court.

CMS says Medicare Advantage and Part D coverage will remain broadly stable in 2027, with lower average premiums and continued plan choice.

House Democrats propose reversing healthcare cuts, protecting vaccine access, lowering costs, and expanding coverage in the next Congress.

Zordani discusses how modern organizations can produce consequential outcomes that no individual person actually chose.

Debates over leadership at the CDC and FDA underscore growing concerns about scientific independence and public trust in health agencies.